score:-5
Chances:
- Danaher (DHR) to Acquire Abcam, Boost Life Sciences Unit
- Danaher Buys Abcam for $5.7 Billion to Expand Its Product Offerings
- Here’s Why Abcam plc (ABCM) Outperformed in Q2
- Abcam Highlights Successful Execution of Strategic Priorities to Drive Shareholder Value
- NanoString and Abcam Expand Collaboration to Advance Spatial Multiomics Research
Risks:
- Abcam shares fall after $5.7 billion acquisition by Danaher announced
- Danaher reaches $5.7B deal to acquire Abcam
- Abcam Announces Review of Strategic Alternatives
- A biotechnology product supplier is shuttering its office in Milpitas and cutting 30 workers
- Edited Transcript of ABCA.L earnings conference call or presentation 12-Sep-22 12:00pm GMT
Score:-5
investment score = chances characters count - risks characters count
References:
- 2023-09-01 Abcam plc Interim Results for the Six-Month Period Ended 30 June 2023
- 2023-08-30 Danaher (DHR) to Acquire Abcam, Boost Life Sciences Unit
- 2023-08-29 Danaher Buys Abcam for $5.7 Billion to Expand Its Product Offerings
- 2023-08-29 Danaher/Abcam: UK biotech went in search of US investors and found a US buyer
- 2023-08-28 Danaher to Buy Abcam in $5.7 Billion Deal. Investors Don’t Like the Premium.
- 2023-08-28 Danaher reaches $5.7B deal to acquire Abcam
- 2023-08-28 UPDATE 1-Danaher to buy Abcam in deal valued at $5.7 billion
- 2023-08-28 Danaher to acquire Abcam for $24.00 per Share
- 2023-08-28 Danaher to Acquire Abcam
- 2023-08-28 Abcam shares fall after $5.7 billion acquisition by Danaher announced